{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:00:14Z","timestamp":1771012814456,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":928,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/ijcp.12135","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T09:57:38Z","timestamp":1360922258000},"page":"544-551","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates"],"prefix":"10.1155","volume":"67","author":[{"given":"U.","family":"Capitanio","sequence":"first","affiliation":[{"name":"Department of Urology; Vita Salute San Raffaele University; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salonia","sequence":"additional","affiliation":[{"name":"Department of Urology; Vita Salute San Raffaele University; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Briganti","sequence":"additional","affiliation":[{"name":"Department of Urology; Vita Salute San Raffaele University; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Montorsi","sequence":"additional","affiliation":[{"name":"Department of Urology; Vita Salute San Raffaele University; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"10.1111\/ijcp.12135-BIB0001|ijcp12135-cit-0001","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.eururo.2011.08.055","article-title":"Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities","volume":"60","author":"Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0002|ijcp12135-cit-0002","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1464-410X.2011.10808.x","article-title":"Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice","volume":"110","author":"Oelke","year":"2012","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0003|ijcp12135-cit-0003","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0004|ijcp12135-cit-0004","first-page":"S83","article-title":"An assessment of the diagnosed prevalence of diseases in men 50\u00a0years of age or older","volume":"12","author":"Issa","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1111\/ijcp.12135-BIB0005|ijcp12135-cit-0005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.juro.2008.03.014","article-title":"Commentary on BPH and public health - have we lost the forest through the trees?","volume":"179","author":"Parsons","year":"2008","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0006|ijcp12135-cit-0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2009.03.080","article-title":"Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland","volume":"57","author":"Tikkinen","year":"2010","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0007|ijcp12135-cit-0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2011.05.065","article-title":"Nocturia and quality of life: results from the Boston area community health survey","volume":"61","author":"Kupelian","year":"2012","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0008|ijcp12135-cit-0008","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0009|ijcp12135-cit-0009","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","article-title":"Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies","volume":"181","author":"Marks","year":"2009","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0010|ijcp12135-cit-0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","article-title":"Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men","volume":"98","author":"Kawabe","year":"2006","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0011|ijcp12135-cit-0011","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1464-410X.2011.10233.x","article-title":"Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)","volume":"108","author":"Yu","year":"2011","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0012|ijcp12135-cit-0012","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0022-5347(17)47714-7","article-title":"Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate","volume":"134","author":"Hedlund","year":"1985","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0013|ijcp12135-cit-0013","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1464-410X.1991.tb15193.x","article-title":"Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia","volume":"67","author":"Lepor","year":"1991","journal-title":"Br J Urol"},{"key":"10.1111\/ijcp.12135-BIB0014|ijcp12135-cit-0014","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00345-001-0237-0","article-title":"Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists","volume":"19","author":"Andersson","year":"2002","journal-title":"World J Urol"},{"key":"10.1111\/ijcp.12135-BIB0015|ijcp12135-cit-0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2007.11.003","article-title":"In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs","volume":"580","author":"Noguchi","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ijcp.12135-BIB0016|ijcp12135-cit-0016","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1996.tb15742.x","article-title":"Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue","volume":"119","author":"Nasu","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"Suppl. 2","key":"10.1111\/ijcp.12135-BIB0017|ijcp12135-cit-0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000052229","article-title":"Functional uroselectivity","volume":"33","author":"Martin","year":"1998","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0018|ijcp12135-cit-0018","first-page":"8","article-title":"BHP: Silodosin an effective new drug for BPH-associated LUTS","volume":"8","author":"Warde","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1111\/ijcp.12135-BIB0019|ijcp12135-cit-0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1442-2042.2011.02810.x","article-title":"Efficacy of selective alpha1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones","volume":"18","author":"Itoh","year":"2011","journal-title":"Int J Urol"},{"key":"10.1111\/ijcp.12135-BIB0020|ijcp12135-cit-0020","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1111\/j.1464-410X.2011.10814.x","article-title":"Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat","volume":"110(2 Pt 2)","author":"Inoue","year":"2012","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0021|ijcp12135-cit-0021","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/11204780-000000000-00000","article-title":"Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia","volume":"71","author":"Curran","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1111\/ijcp.12135-BIB0022|ijcp12135-cit-0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2165\/11207800-000000000-00000","article-title":"Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report","volume":"28","author":"Curran","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1111\/ijcp.12135-BIB0023|ijcp12135-cit-0023","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0026-895X(25)10243-5","article-title":"KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues","volume":"48","author":"Shibata","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1111\/ijcp.12135-BIB0024|ijcp12135-cit-0024","first-page":"S1","article-title":"Efficacy of alpha-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms","volume":"11","author":"Roehrborn","year":"2009","journal-title":"Rev Urol"},{"key":"10.1111\/ijcp.12135-BIB0025|ijcp12135-cit-0025","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.juro.2009.08.030","article-title":"Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study","volume":"182","author":"Matsukawa","year":"2009","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0026|ijcp12135-cit-0026","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/nau.20802","article-title":"Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia","volume":"29","author":"Yamanishi","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/ijcp.12135-BIB0027|ijcp12135-cit-0027","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.2009.265","article-title":"Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study","volume":"87","author":"Morganroth","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/ijcp.12135-BIB0028|ijcp12135-cit-0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjp.0707369","article-title":"Alpha1-adrenoceptors and ejaculatory function","volume":"152","author":"Michel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1111\/ijcp.12135-BIB0029|ijcp12135-cit-0029","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2006.06.004","article-title":"Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0030|ijcp12135-cit-0030","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.clinthera.2009.11.024","article-title":"Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia","volume":"31","author":"Schilit","year":"2009","journal-title":"Clin Ther"},{"key":"10.1111\/ijcp.12135-BIB0031|ijcp12135-cit-0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpuro1276","article-title":"Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine","volume":"6","author":"Kojima","year":"2009","journal-title":"Nat Clin Pract Urol"},{"issue":"Suppl. 2","key":"10.1111\/ijcp.12135-BIB0032|ijcp12135-cit-0032","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1464-410X.2006.06104.x","article-title":"Impact of medical treatments for benign prostatic hyperplasia on sexual function","volume":"97","author":"Giuliano","year":"2006","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0033|ijcp12135-cit-0033","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1442-2042.2008.02136.x","article-title":"Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: a preliminary study to analyze human ejaculation using color Doppler ultrasonography","volume":"15","author":"Nagai","year":"2008","journal-title":"Int J Urol"},{"key":"10.1111\/ijcp.12135-BIB0034|ijcp12135-cit-0034","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/pcan.2010.46","article-title":"Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH","volume":"14","author":"Roehrborn","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1111\/ijcp.12135-BIB0035|ijcp12135-cit-0035","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.urology.2010.03.015","article-title":"Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia","volume":"76","author":"Homma","year":"2010","journal-title":"Urology"},{"key":"10.1111\/ijcp.12135-BIB0036|ijcp12135-cit-0036","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1592\/phco.30.12.1303","article-title":"Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability","volume":"30","author":"Lepor","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ijcp.12135-BIB0037|ijcp12135-cit-0037","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-410X.2005.05408.x","article-title":"Nocturia, depression and antidepressant medication","volume":"95","author":"Asplund","year":"2005","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0038|ijcp12135-cit-0038","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1464-410X.2005.05407.x","article-title":"Nocturia in relation to somatic health, mental health and pain in adult men and women","volume":"95","author":"Asplund","year":"2005","journal-title":"BJU Int"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12135-BIB0039|ijcp12135-cit-0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1464-410X.2005.05653.x","article-title":"Nocturia in relation to sleep, health, and medical treatment in the elderly","volume":"96","author":"Asplund","year":"2005","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12135-BIB0040|ijcp12135-cit-0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.juro.2010.09.108","article-title":"Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey","volume":"185","author":"Kupelian","year":"2011","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0041|ijcp12135-cit-0041","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eursup.2010.04.001","article-title":"Profile of silodosin","volume":"9","author":"Montorsi","year":"2010","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/ijcp.12135-BIB0042|ijcp12135-cit-0042","doi-asserted-by":"crossref","unstructured":"Michel M Casi M Antonellini A Silodosin consistently improves nocturia in men with LUTS suggestive of BPH. Analysis of three phase III placebo-controlled studies. EAU 26th Annual Meeting Vienna 2011","DOI":"10.1016\/S1569-9056(11)60327-8"},{"key":"10.1111\/ijcp.12135-BIB0043|ijcp12135-cit-0043","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"Nunzio","year":"2012","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12135-BIB0044|ijcp12135-cit-0044","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.urology.2011.09.039","article-title":"Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia","volume":"79","author":"Chen","year":"2012","journal-title":"Urology"},{"key":"10.1111\/ijcp.12135-BIB0045|ijcp12135-cit-0045","unstructured":"Agency EM CHMP ASSESSMENT REPORT FOR Silodyx. Doc.Ref.: EMA\/72316\/2010. Procedure No. EMEA\/H\/C\/001209. 2010 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/001209\/WC500074188.pdf"},{"key":"10.1111\/ijcp.12135-BIB0046|ijcp12135-cit-0046","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.urology.2009.10.042","article-title":"Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men","volume":"75","author":"MacDiarmid","year":"2010","journal-title":"Urology"},{"key":"10.1111\/ijcp.12135-BIB0047|ijcp12135-cit-0047","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1442-2042.2010.02614.x","article-title":"Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"17","author":"Miyakita","year":"2010","journal-title":"Int J Urol"},{"key":"10.1111\/ijcp.12135-BIB0048|ijcp12135-cit-0048","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.juro.2011.03.028","article-title":"Silodosin for men with chronic prostatitis\/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study","volume":"186","author":"Nickel","year":"2011","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0049|ijcp12135-cit-0049","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.juro.2009.08.106","article-title":"Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage","volume":"183","author":"Kobayashi","year":"2010","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12135-BIB0050|ijcp12135-cit-0050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.urology.2010.09.034","article-title":"Characterization of alpha1-adrenoceptor subtypes mediating contraction in human isolated ureters","volume":"77","author":"Sasaki","year":"2011","journal-title":"Urology"},{"key":"10.1111\/ijcp.12135-BIB0051|ijcp12135-cit-0051","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00240-007-0118-0","article-title":"Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter","volume":"35","author":"Park","year":"2007","journal-title":"Urol Res"},{"key":"10.1111\/ijcp.12135-BIB0052|ijcp12135-cit-0052","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1540\/jsmr.45.187","article-title":"Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters","volume":"45","author":"Kobayashi","year":"2009","journal-title":"J Smooth Muscle Res"},{"key":"10.1111\/ijcp.12135-BIB0053|ijcp12135-cit-0053","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1442-2042.2011.02850.x","article-title":"Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients","volume":"18","author":"Tsuzaka","year":"2011","journal-title":"Int J Urol"},{"key":"10.1111\/ijcp.12135-BIB0054|ijcp12135-cit-0054","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/j.ijrobp.2011.04.026","article-title":"Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial","volume":"81","author":"Tsumura","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12135","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:24:28Z","timestamp":1745961868000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12135","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,15]]},"assertion":[{"value":"2013-02-15","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}